Glaxo To Take $2.4 Billion Hit Over Avandia Cases
Category: Avandia
More Info: Defective Drugs
Even for a flush drugmaker like GlaxoSmithKline, $2.4 billion dollars is a lot of money to wipe off the books in a single quarter.
Yet, just hours after a panel of U.S. experts voted in favor of keeping Glaxo’s diabetes pill Avandia on the market, despite known heart risks, that’s what the drugmaker said it would do in its second quarter.
All that money wil go to cover the cost of a bunch of legal problems, including the settlement of lawsuits over harm allegedly linked to Avandia.
The company said “the substantial majority of the product liability cases relating to Avandia have now been settled.” Glaxo hasn’t disclosed how much money that involves. But Bloomberg reported the company has already agreed to pay about $460 million to put those cases to rest.
It could have been worse. Before the meeting of experts advising the Food and Drug Administration on Avandia concluded Tuesday, some analysts figured the Avandia costs could run as high as $6 billion, Reuters reported.
Continue reading...
See the full, original post here: https://www.npr.org/sections/health-shots/2010/07/15/128534637/glaxo-takes-2-4-billion-charge-to-cover-avandia-cases
About TriMark Legal Funding
TriMark was established in 2003 and is among the oldest legal funding companies in the nation. TriMark provides pre-settlement and post-settlement funding, sometimes called 'lawsuit settlement loans', to injured plaintiffs on hundreds of different types of personal injury lawsuits, employment lawsuits, workplace injury accidents and worker's comp lawsuits, mass torts, and multi-district litigation. We also provide attorney funding and law firm financing for plaintiffs' attorneys and law firms.
Personal Injury Legal Funding | Multidistrict Litigation Financing |
Click here to see the original article.